You have 9 free searches left this month | for more free features.

Condition

Dry Eye Syndrome (2)

Neurotrophic Keratopathy (2)

Dry Eye (1)

Dry Eye Syndromes (1)

Overall Status

Completed (3)

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 3 (4)

phase 2/phase 3 (1)

Sponsor

ReGenTree, LLC (5)

Collaborator

Intervention

placebo (5)

rgn-259 (5)

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (5)

Study Type

Interventional (5)

rgn-259

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neurotrophic Keratopathy Trial (RGN-259, Placebo)

Not yet recruiting

Neurotrophic Keratopathy

RGN-259
Placebo

(no location specified)

Sep 22, 2022

Dry Eye Syndrome Trial in Andover (RGN-259, Placebo)

Completed

Dry Eye Syndrome

RGN-259
Placebo

Andover, Massachusetts

Andover, MA

Dec 9, 2021

Dry Eye Syndromes, Dry Eye Trial in United States (RGN-259, Placebo)

Completed

Dry Eye Syndromes
Dry Eye

RGN-259
Placebo

Phoenix, Arizona
+19 more

May 2, 2022

Neurotrophic Keratopathy Trial in United States (RGN-259, Placebo)

Terminated

Neurotrophic Keratopathy

RGN-259
Placebo

Lancaster, California
+10 more

Jun 30, 2020

Dry Eye Syndrome Trial in Andover (RGN-259, Placebo)

Completed

Dry Eye Syndrome

RGN-259
Placebo

Andover, Massachusetts

Andover, MA

Oct 7, 2019